Latest Financial Results
Q1 2022
Quarter Ended Mar 31, 2022
Stock Information
Company Overview
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investor Contact Information
Company
Kane Biotech Inc.
290-100 Innovation Drive
Winnipeg, MB R3T 6G2
Canada
T: (250) 327 8675
ir@kanebiotech.com
Investor Relations
Jonathan Paterson
Managing Partner
263 Tresser Blvd 9th Fl
Stamford, CT 06901
USA
T: (203) 862 0492
jonathan.paterson@harboraccessllc.com
Kane Biotech Inc.
Nicole Sendey
Investor Relations & Public Relations
T: 250-327-8675
nsendey@kanebiotech.com
Transfer Agent
Canadian Stock Transfer Company Inc.
600, 333 – 7th Avenue S.W.
Calgary, Alberta T2P 2Z1